MedPAC chair defends Medicare Advantage overpayment analysis at insurer lobby event

Amid growing public debate over how best to analyze spending in MA versus traditional Medicare, Dr. Amol Navathe, the leader of the group behind the most-cited estimate, stepped into the lion’s den to support its work.